Thank you for Subscribing to Life Science Review Weekly Brief
Science 37 and Syneos Health will work together to provide biopharmaceutical companies with a single, streamlined technology framework for workflow orchestration, real-world evidence generation, and data harmonization.
FREMONT, CA: Syneos Health, the only fully integrated biopharmaceutical solutions company, and Science 37, the industry’s Decentralized Clinical Trial Operating System, announced a strategic partnership to enable enhanced decentralized clinical trial delivery. Science 37 and Syneos Health will work together to provide biopharmaceutical companies with a single, streamlined technology framework for workflow orchestration, real-world evidence generation, and data harmonization.
“Increasing clinical trial access and diversity is a scientific, business and ethical imperative as we continually look for ways to improve patient outcomes and eliminate healthcare disparities,” said Alistair Macdonald, Chief Executive Officer, Syneos Health. “Our powerful partnership with Science 37 adds their industry-leading platform to our Decentralized Solutions and, when combined with the mobile research nursing capabilities delivered through our Illingworth Research team, we’re able to open new pathways toward the long-sought goal of placing patients at the center of clinical research.”
Decentralized trials have been on the rise as companies look for new ways to improve performance, cut costs, and get trials closer to patients. These experiments, made possible by digital technology, provide:
New ways to reach more diversity.
Representative patient groups.
Reduce the burden and increase access for patients who could not previously participate in clinical trial research
Syneos Health’s Decentralized Solutions incorporates deep behavioral and therapeutic perspectives, agile technology, and organizational excellence to put clinical trials closer to patients and transform product growth. Through its open, on-demand network of patient groups, telemedicine investigators, mobile nurses, remote coordinators, and connected devices, Science 37’s premier technology platform allows virtual clinical trials, improving clinical and real-world efficacy, and yielding high-quality data collection.
“Partnering with Syneos Health extends our mission to accelerate research and enable universal patient and provider access with one of the world’s most prolific providers of clinical research services,” said David Coman, Chief Executive Officer, Science 37. “Our technology will empower the Syneos Health decentralized trial workflow, and our full Operating System will enable access to our patient communities, telemedicine investigators, and remote coordinator networks to harmonize and deliver complex decentralized clinical and real-world studies.”
The Syneos Health Dynamic Assembly network includes Science 37. Dynamic Assembly is a collaborative network of best-in-class data and technology partners dedicated to providing fit-for-purpose solutions that strategically resolve the complexities of each customer interaction. Syneos Health joins the Science 37 CRO Certified program, which provides access, preparation, and commercial support to CROs so they can successfully execute decentralized clinical studies at scale.